The correlation of HIGD2A high expression and poor patient survival is significant for liver hepatocellular carcinoma; cutaneous skin melanoma; uterine corpus endometrial carcinoma; and uveal melanoma (Figure 8). Here, HIGD2A is linked to uterine corpus endometrial carcinoma.